1-6 of 6
Jun Guo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Free
Guangmin Li, Jun Guo, Ben-Quan Shen, Daniela Bumbaca Yadav, Mark X. Sliwkowski, Lisa M. Crocker, Jennifer A. Lacap, Gail D. Lewis Phillips
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2018) 17 (7): 1441–1453.
https://doi.org/10.1158/1535-7163.MCT-17-0296
Published: 01 July 2018
View articletitled, Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells
Open the PDF for Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors

Free
Julie L. Wilsbacher, Min Cheng, Dong Cheng, Samuel A.J. Trammell, Yan Shi, Jun Guo, Stormy L. Koeniger, Peter J. Kovar, Yupeng He, Sujatha Selvaraju, H. Robin Heyman, Bryan K. Sorensen, Richard F. Clark, T. Matthew Hansen, Kenton L. Longenecker, Diana Raich, Alla V. Korepanova, Steven Cepa, Danli L. Towne, Vivek C. Abraham, Hua Tang, Paul L. Richardson, Shaun M. McLoughlin, Ilaria Badagnani, Michael L. Curtin, Michael R. Michaelides, David Maag, F. Gregory Buchanan, Gary G. Chiang, Wenqing Gao, Saul H. Rosenberg, Charles Brenner, Chris Tse
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (7): 1236–1245.
https://doi.org/10.1158/1535-7163.MCT-16-0819
Published: 04 July 2017
View articletitled, Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Open the PDF for Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors in another window
Includes: Supplementary data
Journal Articles

Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo

Free
Xu-Dong Tang, Guo-Zhen Wang, Jun Guo, Mu-Han Lü, Chuan Li, Ning Li, Ya-Ling Chao, Chang-Zhu Li, Yu-Yun Wu, Chang-Jiang Hu, Dian-Chun Fang, Shi-Ming Yang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (5): 1183–1192.
https://doi.org/10.1158/1535-7163.MCT-11-0607
Published: 08 May 2012
View articletitled, Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo
Open the PDF for Multiple Antigenic Peptides Based on H-2Kb–Restricted CTL Epitopes from Murine Heparanase Induce a Potent Antitumor Immune Response In Vivo in another window
Journal Articles

Abstract A239: Preclinical characterization of ABT-348, a kinase inhibitor targeting the Aurora, VEGFR/PDGFR, and SRC kinase families.

Free
Keith B. Glaser, Junling Li, Patrick A. Marcotte, Terrance J. Magoc, Jun Guo, David R. Reuter, Paul Tapang, Ru-Qi Wei, Lori J. Pease, Mai H. Bui, Zehan Chen, Robin R. Frey, Eric F. Johnson, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Michael L. Curtin, Cherrie K. Donawho, Michael R. Michaelides, Chris Tse, Steven K. Davidsen, Daniel H. Albert
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A239.
https://doi.org/10.1158/1535-7163.TARG-11-A239
Published: 12 November 2011
View articletitled, Abstract A239: Preclinical characterization of ABT-348, a kinase inhibitor targeting the Aurora, VEGFR/PDGFR, and SRC kinase families.
Journal Articles

Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors

Free
Jun Guo, Patrick A. Marcotte, J. Owen McCall, Yujia Dai, Lori J. Pease, Michael R. Michaelides, Steven K. Davidsen, Keith B. Glaser
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 1007–1013.
https://doi.org/10.1158/1535-7163.MCT-05-0359
Published: 28 April 2006
View articletitled, Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors
Open the PDF for Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors in another window
Journal Articles

Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor

Free
Daniel H. Albert, Paul Tapang, Terrance J. Magoc, Lori J. Pease, David R. Reuter, Ru-Qi Wei, Junling Li, Jun Guo, Peter F. Bousquet, Nayereh S. Ghoreishi-Haack, Baole Wang, Gail T. Bukofzer, Yi-Chun Wang, Jason A. Stavropoulos, Kresna Hartandi, Amanda L. Niquette, Nirupama Soni, Eric F. Johnson, J. Owen McCall, Jennifer J. Bouska, Yanping Luo, Cherrie K. Donawho, Yujia Dai, Patrick A. Marcotte, Keith B. Glaser, Michael R. Michaelides, Steven K. Davidsen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 995–1006.
https://doi.org/10.1158/1535-7163.MCT-05-0410
Published: 28 April 2006
View articletitled, Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor
Open the PDF for Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor in another window